US7063865B2ExpiredUtilityA1

Composition and method for substantially reducing the deleterious effects of alcohol on the body

Assignee: JONES JEREMY PARKPriority: May 10, 2002Filed: May 10, 2002Granted: Jun 20, 2006
Est. expiryMay 10, 2022(expired)· nominal 20-yr term from priority
A61K 38/063A61K 31/198A61K 31/51A61P 3/02A61K 33/04A61K 33/24
67
PatentIndex Score
7
Cited by
3
References
6
Claims

Abstract

A composition that will substantially reduce the deleterious effects of alcohol on the body and substantially reduce the side effects associated with hangovers (i.e. headaches, dizziness, nausea, dry mouth, etc) when taken as recommended. The composition includes an effective amount of (I)-glycine, (I)-glutathione, thiamine, magnesium, selenium, molybdenum. Other vitamins, mineral compounds, flavoring, coloring, and solubility agents may also be added.

Claims

exact text as granted — not AI-modified
1. A composition comprising:
 about 1 g to 2 g glycine; 
 25 mg to 250 mg L-glutathione; 
 3 mg to 800 mg magnesium; 
 25 microgram to 250 microgram molybdenum; 
 10 microgram to 200 microgram selenium; and 
 2 mg to 20 mg thiamine (vitamin B1), 
 
       wherein the composition, when consumed by a person before and/or during consumption of alcoholic beverages, substantially reduces the deleterious effects of alcohol on the body and substantially reduces the side-effects associated with a hangover selected from the group consisting of heache, dizziness, nausea and dry mouth. 
     
     
       2. The composition of  claim 1 , wherein a 4 g sample composition comprises 1 g of glycine, 25 mg of L-glutathione, 17 mg total thiamine (vitamin B1) compounds, 38 mg total magnesium compound(s), 25 microgram molybdenum, and 17 microgram selenium, wherein the composition, when consumed by a person before and/or during consumption of alcoholic beverages, substantially reduces the deleterious effects of alcohol on the body and substantially reduces the side-effects associated with a hangover selected from the group consisting of heache, dizziness, nausea and dry mouth. 
     
     
       3. The composition of  claim 1 , wherein the active amount of L-glutathione is 25 mg, glycine is 1 g, magnesium is 7.2 mg, molybdenum is 50 microgram, selenium is 33 microgram, and thiamine (vitamin B1) is 17 mg. 
     
     
       4. The composition of  claim 1 , wherein the composition further comprises at least one calcium compound, at least one chromium compound, at least one manganese compound, at least one zinc compound, ascorbic acid, caffeine, potassium hydrogen carbonate, tartaric acid, at least one cobalamin compound (vitamin B12), and at least one pyridoxine compound (vitamin B6). 
     
     
       5. The composition of  claim 1 , further comprising an effective amount of at least one coloring agent, and/or at least one flavoring agent. 
     
     
       6. The composition of  claim 1 , wherein the composition is formulated to be taken orally.

Join the waitlist — get patent alerts

Track US7063865B2 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.